Loading…

Browse All Grants

606,025 grants found

Filters
Reset

Showing 27,92127,940 of 606,025 grants

Active NON-SBIR/STTR RPGS
Leveraging community-to-facility service provision to implement the World Health Organization HEARTS-D guidelines in Bangladesh for improving diabetes control and prevention.
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE Florida International University United States 2024 – 2029

PROJECT SUMMARY Type-2 diabetes (T2D) is rising at an alarming rate in most of low- and middle-income countries (LMIC). This rapid increase in the T2D burden has a particular impac...

$6.27M
USD
Active NON-SBIR/STTR RPGS
Protein sequence influence on single-molecule transport dynamics
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES Columbia University New York Morningside United States 2024 – 2028

ATP-Binding Cassette (ABC) Transporters are paradigmatic molecular machines that use ATP binding and hydrolysis to power transmembrane transport of diverse substrates. Knowledge of...

$3.24M
USD
Active NON-SBIR/STTR RPGS
Impact of Ethnicity on the Utility of Plasma Amyloid and Tau to Predict Alzheimer's Disease
NATIONAL INSTITUTE ON AGING University of Southern California United States 2024 – 2029

ABSTRACT The development of biomarkers for Alzheimer’s disease resulted in the use of positron emission tomography (PET) and biofluid assays to detect AD pathology before clinical...

$5.94M
USD
Active NON-SBIR/STTR RPGS
Basal Forebrain Non-cholinergic Circuit Mechanisms of Sustained Attention
NATIONAL INSTITUTE OF MENTAL HEALTH Washington University United States 2024 – 2029

ABSTRACT The long-term goal is to understand how basal forebrain (BF) circuits underlie cognitive functions like sustained attention. Traditionally, BF was thought to mediate atten...

$5.82M
USD
Active NON-SBIR/STTR RPGS
Assessing the efficacy of a ROR1:PD-L1:CD2 multispecific T cell engager in ROR1-positive and -negative neuroblastoma models
NATIONAL CANCER INSTITUTE Seattle Children'S Hospital United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT Few children with recurrent neuroblastoma survive. New therapies, particularly immunotherapies, are badly needed. Some promising results have recently been...

$5.03M
USD
Active NON-SBIR/STTR RPGS
Adapting and testing a smoking cessation intervention for transgender and gender-diverse individuals
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2024 – 2026

Despite the substantial decrease in the prevalence of smoking over the past 50-years, there are persistent and significant disparities in tobacco use among transgender and gender d...

$4.4M
USD
Completed NON-SBIR/STTR RPGS
1/2 Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE Cleveland Clinic Lerner Com-Cwru United States 2024 – 2025

Project Summary/Abstract Despite advances in medical therapy for pulmonary arterial hypertension (PAH), mortality rates are still unacceptably high. This may be partly due to the l...

$4.33M
USD
Active OTHER RESEARCH-RELATED
A Virtual, Group-Based, Expressive Writing Intervention for Survivors of Adolescent and Young Adult Cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT Adolescent and young adult cancer survivors (AYACSs) face multiple disparities, including impaired psychosocial health, isolation, limited access to psycho...

$1.61M
USD
Active OTHER RESEARCH-RELATED
Delineating the neural computational network for object recognition
NATIONAL EYE INSTITUTE Washington University United States 2024 – 2026

Project Summary/Abstract A core function of the human brain is object recognition, which underlies many higher-order functions like memory and emotion. Deficits in recognizing obje...

$1.14M
USD
Active NON-SBIR/STTR RPGS
ApolipoproteinL1 Genotypes and Biomarkers of Immune Activation and Tubular Injury
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND K... Boston Medical Center United States 2024 – 2026

PROJECT SUMMARY Chronic Kidney Disease (CKD) can effectively be a death sentence in sub-Saharan Africa where

$1.34M
USD
Active NON-SBIR/STTR RPGS
Leveraging 30 years of Alzheimer's disease clinical trials data to decipher phenotypic response to treatment
NATIONAL INSTITUTE ON AGING University of California, San Diego United States 2024 – 2027

PROJECT SUMMARY Looking back to move forward: The overall goal of this proposal is to examine the role of specific phenotypes, or subgroups of people based on a given characteristi...

$32.81M
USD
Active NON-SBIR/STTR RPGS
Expanding Inclusion of All Subjects for Ultra-High Density Wearable fNIRS in the Everyday World
NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOEN... Boston University (Charles River Campus United States 2024 – 2026

Abstract There is a great need to enable scientists to link brain activity to human movement, perception and cognition, and social communication and interaction continuously, in re...

$4.23M
USD
Active NON-SBIR/STTR RPGS
Decoding the Brain-Liver Axis: Uncovering mechanisms of host defense
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... University of California Berkeley United States 2024 – 2029

This research proposal seeks to uncover neuronal mechanisms orchestrating metabolic adaptations to bacterial infections, specifically delineating the pivotal role of the brain-live...

$4.51M
USD
Active OTHER RESEARCH-RELATED
Age-Related Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Exercise Responsiveness
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE Duke University United States 2024 – 2026

Despite advances in diagnostic and therapeutic paradigms, cardiovascular disease (CVD) remains a primary cause of death across the world. Traditional risk factors for CVD are prima...

$1.05M
USD
Active OTHER RESEARCH-RELATED
Piloting an Implementation Strategy for Mainstream Genetic Testing in Colorectal Cancer
NATIONAL CANCER INSTITUTE University of Alabama At Birmingham United States 2024 – 2029

PROJECT SUMMARY Of the 150,000 individuals diagnosed with colorectal cancer (CRC) each year, 15% will carry a hereditary pathogenic germline variant (PGV) including some associated...

$1.92M
USD
Active OTHER RESEARCH-RELATED
Multi-modal sensory feedback mechanisms of fine and gross motor control in autism spectrum disorders
NATIONAL INSTITUTE OF MENTAL HEALTH University of Kansas Lawrence United States 2024 – 2029

PROJECT SUMMARY The PI’s long-term goal is to become an independent researcher characterizing neurodevelopmental and phys- iologic mechanisms of sensorimotor integration in autism...

$1.48M
USD
Active OTHER RESEARCH-RELATED
Modulatory effects of a retinoid-related protein on intestinal endocrine cells
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND K... Columbia University Health Sciences United States 2024 – 2029

PROJECT SUMMARY The gastrointestinal tract is the largest endocrine organ in the human body. This is due to the presence of intestinal endocrine cells, a scarce yet important cell...

$1.67M
USD
Active NON-SBIR/STTR RPGS
Community Mitigation Against Xylazine
NATIONAL INSTITUTE ON DRUG ABUSE Research Triangle Institute United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT We propose to use the Behavioral Model for Vulnerable Populations as a framework to examine the feasibility and acceptability of a community-based drug che...

$2.12M
USD
Active OTHER RESEARCH-RELATED
Rest/Active Phase Specificity of APOE4 and Inflammation on Respiratory Plasticity
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE University of Florida United States 2024 – 2026

PROJECT SUMMARY This K99/R00 Pathway to Independence Award is designed so that the candidate will achieve her long-term goal of establishing an independent research career focused...

$1.32M
USD
Active OTHER RESEARCH-RELATED
Master - 2/2 Empaglifozin To Improve Right Ventricular Function in Pulmonary Arterial Hypertension
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE Cleveland Clinic Lerner Com-Cwru United States 2024 – 2030

DCC Project Summary Abstract Despite advances in medical therapy for pulmonary arterial hypertension (PAH), mortality rates remain high. Empagliflozin to Improve Right Ventricular...

$3.71M
USD